Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2018 1
2019 1
2020 1
2021 4
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Chemotherapy-induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer.
Hugendieck G, Lettau M, Andreas S, Neumann S, Reinhardt N, Arnold P, Theilig F, Bastian L, Rogmans C, Weimer JP, Flörkemeier I, Wesch D, Arnold N, Maass N, Janssen O, Bauerschlag D, Hedemann N. Hugendieck G, et al. Among authors: hedemann n. J Extracell Vesicles. 2023 Jul;12(7):e12338. doi: 10.1002/jev2.12338. J Extracell Vesicles. 2023. PMID: 37408115 Free PMC article.
γδ T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids.
Dong J, Holthaus D, Peters C, Koster S, Ehsani M, Quevedo-Olmos A, Berger H, Zarobkiewicz M, Mangler M, Gurumurthy RK, Hedemann N, Chumduri C, Kabelitz D, Meyer TF. Dong J, et al. Among authors: hedemann n. Front Immunol. 2023 Nov 27;14:1281646. doi: 10.3389/fimmu.2023.1281646. eCollection 2023. Front Immunol. 2023. PMID: 38090581 Free PMC article.
Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages.
Rogmans C, Feuerborn J, Treeck L, Tribian N, Flörkemeier I, Arnold N, Weimer JP, Maass N, Jansen P, Lieb W, Dempfle A, Bauerschlag DO, Hedemann N. Rogmans C, et al. Among authors: hedemann n. Cancers (Basel). 2022 Nov 29;14(23):5867. doi: 10.3390/cancers14235867. Cancers (Basel). 2022. PMID: 36497350 Free PMC article.
ADAM17 inhibition enhances platinum efficiency in ovarian cancer.
Hedemann N, Rogmans C, Sebens S, Wesch D, Reichert M, Schmidt-Arras D, Oberg HH, Pecks U, van Mackelenbergh M, Weimer J, Arnold N, Maass N, Bauerschlag DO. Hedemann N, et al. Oncotarget. 2018 Mar 23;9(22):16043-16058. doi: 10.18632/oncotarget.24682. eCollection 2018 Mar 23. Oncotarget. 2018. PMID: 29662625 Free PMC article.
Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non-invasive vaginal swab.
Weimer J, Hüttmann M, Nusilati A, Andreas S, Röseler J, Tribian N, Rogmans C, Stope MB, Dahl E, Mustea A, Stickeler E, Hedemann N, Flörkemeier I, Tiemann K, Magadeeva S, Dempfle A, Arnold N, Maass N, Bauerschlag D. Weimer J, et al. Among authors: hedemann n. J Cell Mol Med. 2023 Feb;27(3):379-391. doi: 10.1111/jcmm.17658. Epub 2023 Jan 10. J Cell Mol Med. 2023. PMID: 36625073 Free PMC article.
ADAM17-A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer.
Rogmans C, Kuhlmann JD, Hugendieck G, Link T, Arnold N, Weimer JP, Flörkemeier I, Rambow AC, Lieb W, Maass N, Bauerschlag DO, Hedemann N. Rogmans C, et al. Among authors: hedemann n. Cancers (Basel). 2021 Nov 6;13(21):5563. doi: 10.3390/cancers13215563. Cancers (Basel). 2021. PMID: 34771725 Free PMC article.
16 results